
By leveraging advanced Wastewater-Based Epidemiology (WBE) to provide real-time, non-intrusive public health and safety insights. By analyzing composite municipal or facility wastewater inflows, we map community-level substance consumption patterns without compromising individual privacy.
Tracks broad population-level consumption trends, shielding individual identities while exposing community risks.
Detects sudden spikes in novel psychoactive substances (NPS) or illicit drug surges days or weeks before they manifest in law enforcement or hospital data.
Equips public health authorities and corporate campuses with objective metrics to measure the efficacy of anti-drug campaigns.
Our laboratories process complex wastewater matrices to extract and quantify stable drug metabolites (biomarkers), distinguishing between actual human consumption and direct disposal. We monitor:
Traditional illicit substances (Cocaine, Amphetamines, Opioids)
Prescription medication abuse profiles
Emerging synthetic compounds and local designer drugs
Helping local governments target healthcare resources and prevention initiatives effectively.
Discretely assessing substance footprints within industrial zones or large-scale residential campuses.